Mutations in BRCA1/2 genes (BRCAm) were most frequently identified in ovarian (OvCa, 15.2%) followed by prostate (PC, 10.7%), breast (BC, 8.8%) and pancreatic cancer (PaC, 5.2%) [12]. This evidence concerns the gene BRCA1 and pachyonychia congenita.